NIH Funding Secured for Development Through Phase 1 of Novel Antibiotic Candidate CRS0540
Crestone, Inc. Secures NIH Funding for Development Through Phase 1 of Novel Antibiotic Candidate...
Read More
Grant Received from State of Colorado Advanced Industries Accelerator program
May 29, 2020. Crestone, Inc. receives $250,000 Grant from State of Colorado Advanced...
Read More
NIH Funding Secured for Preclinical Development of Novel Antibiotic CRS3123
Crestone, Inc. Secures NIH Funding for Preclinical Development of Novel Antibiotic CRS3123 to...
Read More
CFF Funding Secured for Preclinical Development of Novel Antibiotic to Treat NTM Infections
Crestone, Inc. (Boulder) Secures CFF Funding for Preclinical Development of Novel Antibiotic to...
Read More
NIH Funding Secured for Phase 2 Clinical Trial of Novel Antibiotic Candidate, CRS3123
Crestone, Inc. Secures NIH Funding for Phase 2 Clinical Trial of Novel Antibiotic Candidate,...
Read More
Research Agreement with Colorado University at Boulder
Crestone enters a Research Agreement with Colorado University at Boulder to develop efflux pump...
Read More
Crestone Awarded a Phase II SBIR Grant: “Optimization and Lead Selection of Novel Antimycobacterial Agents”
Award Information InfoData Agency:Department of Health and Human Services Branch:National...
Read More
Become a Part of Our Projects
Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investor, a team member, or a participant in our ongoing clinical studies.
Inquiries
Have a question or comment? Follow the link below to contact us about general inquiries.
Careers
Find work in a challenging, team-oriented environment with competitive salaries.
Clinical Studies
Learn how you can become part of our ongoing clinical study to fight deadly GI tract infections.